Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Immunovant, Inc.
Business Segments
Geographic
Research and development tax credit carry forwards
Research and development tax credit carry forwards
Immunovant, Inc.
·
Geographic
·
1 segment
·
Rolls up to
R&D credit carryforward
Breakdown
Segments
United States
View metric
Quarterly
Annual
TTM
Segment
Q4 '22
Q4 '23
Q4 '24
Q4 '25
Q4 '26
United States
$6M
$10.8M
$21.2M
$39.2M
$53.7M
Total
—
—
—
—
—
